Carregant...
Challenges and Opportunities of Allogeneic Donor-Derived CAR T cells
PURPOSE OF REVIEW: As T cells engineered with chimeric antigen receptors (CARs) are entering advanced phases of clinical trial testing with promising results, the potential implications of use in an allogeneic environment is emerging as an important consideration. This review discusses the use of al...
Guardat en:
| Publicat a: | Curr Opin Hematol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636084/ https://ncbi.nlm.nih.gov/pubmed/26390167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0000000000000181 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|